ESC 365 - The prevalence and assessment of cardiovascular symptoms as the risk factors for post-COVID syndrome at 12-month follow-up. Data from the Polish Long-COVID Cardiovascular (PoLoCOV-CVD) Study.

ESC Professional Premium Access

The prevalence and assessment of cardiovascular symptoms as the risk factors for post-COVID syndrome at 12-month follow-up. Data from the Polish Long-COVID Cardiovascular (PoLoCOV-CVD) Study.

Session: COVID-19 and heart disease

Topic: Autoimmune/Chronic Inflammatory Disorders and Heart Disease

Speaker: Professor P. Jankowski (Warsaw, PL)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Professor Piotr Jankowski

The Medical Centre of Postgraduate Education, Warsaw (Poland)

10 presentations

0 follower

3 more presentations in this session

Symptom burden, coagulopathy and heart disease, and quality of life at baseline and after 1-year follow-up following acute SARS-CoV-2 infection in a community medicine setting

Speaker: Doctor R. Colleran (Dublin 7, IE)

The role of the peripheral chemoreceptor reflex in non-hospitalised patients with post-COVID-19 syndrome

Speaker: Doctor A. El-Medany (Bristol, GB)

Postural orthostatic tachycardia syndrome (POTS) and other autonomic dysfunction following COVID-19 infection: incidence, characteristic and associating factors

Speaker: Doctor C. tanking (Bangkok, TH)

Access the full session

COVID-19 and heart disease

Speakers: Professor P. Jankowski, Doctor R. Colleran, Doctor A. El-Medany, Doctor C. tanking

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources